TEMPLATE

Leaders in Learning: Publications of Faculty & Staff

Medicine (Dept.): 1999-2000

ADAMS, P.C.

Adams, P.C. 1999. Diagnosis of hemochromatosis: role of genetic testing and liver biopsy. Current Gastroenterology Reports 1: 27-29.

Adams, P.C. 2000. Hemochromatosis and Liver Transplantation. Hemochromatosis. C.Q. Edwards, and J. Barton. Cambridge: Cambridge University Press. 355-358.

Adams, P.C. 2000. Hemochromatosis: Genetic diagnosis and management. Gastroenterology Rounds, University of Alberta 6 (June/July).

Adams, P.C. 2000. Population screening for haemochromatosis. Gut 46: 301-303.

Adams, P.C., K. Alanen, R. Preshaw, S. Chakrabarti, G. Jeffrey, W. Howson, and D. Grant. 1999. Transplantation of hemochromatosis liver and intestine into a normal recipient. Gut 45: 783.

Adams, P.C., A.E. Kertesz, C.E. McLaren, R.M. Barr, T. Bamford, and S. Chakrabarti. 2000. Population Screening for Hemochromatosis: A Comparison of Unbound Iron-Bindin Capacity, Transferrin Saturation, and C282Y Genotyping in 5, 211 Voluntary Blood Donors. Hepatology 31: 1160-1164.

Alanen, K., S. Chakrabarti, G. Jeffrey, J. Rawlins, W. Howson, and P.C. Adams. 1999. Prevalence of C282Y mutation of the hemochromatosis gene (HFE) in end stage liver disease: a study of liver transplant recipients and donors. Hepatology 30: 665-669.

Arya, N., S. Chakrabarti, R. Hegele, and P.C. Adams. 1999. HFE S65C variant is not associated with an increased transferrin saturation in voluntary blood donors. Blood Cells, Molecules and Diseases 25: 354-357.

Barton, J., S. McDonnell, P.C. Adams, P. Brissot, L.W. Powell, C. Edwards, J. Cook, and K. Kowdley. 2000. Management of Hemochromatosis. Hemochromatosis. C.Q. Edwards, and J. Barton. Cambridge: Cambridge University Press. 329-338.

Jeffrey, G., and P.C. Adams. 1999. Blood from patients with hereditary hemochromatosis - a wasted resource? Transfusion 39: 549-550.

Jeffrey, G., and P.C. Adams. 1999. Hemochromatosis and Wilson Disease: Diagnosis and management strategies. Evidence-Based Gastroenterology. J.W. McDonald, A. Burroughs, and B. Feagan. London: BMJ Books. 333-345.

Jeffrey, G., and P.C. Adams. 2000. Pitfalls in the diagnosis of genetic hemochromatosis. Genetic Testing 4: 143-146.

McLaughlin, K., S. Wajstaub, P.J. Marotta, P.C. Adams, D.R. Grant, W.J. Wall, A.M. Jevnikar, and K.S. Rizkalla. 2000. Increased risk for post-transplant lymphoproliferative disease in recipients of liver transplants with hepatitis C. Liver Transplantation 6 (5): 570-574.

ARNOLD, J.M.O.

Arnold, J.M.O. 2000. Cardiovascular therapeutics: The treatment of heart failure (Chapter 4). Melmon and Morrelli's Clinical Pharmacology: Basic Principles in Therapeutics. 4th ed. S.G. Carruthers, B.B. Hoffman, K.L. Melon, and D.W. Nierenberg. New York: McGraw-Hill. 157-182.

Arnold, J.M.O. 2000. Nitroglycerin improved exercise capacity in patients with chronic HF already treated with ACE inhibitors. Evidence-Based Cardiovascular Medicine 3 (3): 71.

Arnold, J.M.O., and The ATLAS Study Group Study Investigators. 1999. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisopril, on morbibity and mortality in Chronic Heart Failure. Circulation 100: 2312-2318.

Arnold, J.M.O., J. Howlerr, R. Nigam, W. Czarnecki, A. Ignaszewski, M.H. LeBlanc, P. Lieu, J.D. Parker, R. Rajakumar, S. Smith, K. Teo, and I. Belenkie. 1999. The Canadian CHF Clinics Network: Implementation and Initial Results. Canadian Journal of Cardiology 15 (9): 67.

Arnold, J.M.O., I.M. Hramiak, W.J. Kostuk, D.R. Massel, R.M. McManus, and The Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. 2000. Effects of an angiotensin-converting-enzyme inhibitor ramipril on cardiovascular events in high-risk patients. New England Journal of Medicine 342 (3): 145-153.

Arnold, J.M.O., I.M. Hramiak, W.J. Kostuk, D.R. Massel, R.M. McManus, and The Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. 2000. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. New England Journal of Medicine 355 (9200): 253-259.

Arnold, J.M.O., I.M. Hramiak, W.J. Kostuk, D.R. Massel, R.M. McManus, and The Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. 2000. Effects of an Angiotensive-Converting Enzyme Inhibitor, Ramipril, on Death from Cardiovascular Causes, Myocardial Infarction, and Stroke In High-Risk Patients. New England Journal of Medicine 342: 1020-1026.

Arnold, J.M.O., I.M. Hramiak, W.J. Kostuk, D.R. Massel, R.M. McManus, and The Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. 2000. Vitamin E supplementation and cardiovascular events in high-risk patients. New England Journal of Medicine 342 (3): 154-160.

Dzeka, T.N., P. Kuzminski, and J.M.O. Arnold. 1999. Effects of aspirin on venoconstriction to physiological stress-induced sympathetic activation. Circulation 100 (Suppl I): I-136.

Dzeka, T.N., P. Kuzminski, and J.M.O. Arnold. 2000. Venous responsiveness to norepinephrine in healthy subjects: Effects of single doses of 325 mg. Clinical Pharmacology and Therapeutics 67: 299-304.

Feng, Q.P., M.L. Lambert, I.D. Callow, and J.M.O. Arnold. 2000. Venous neuropeptide Y receptor responsiveness in patients with chronic heart failure. Clinical Pharmacology and Therapeutics 67: 292-298.

Gupta, A., and J.M.O. Arnold. 2000. Can I be sure my patient has Congestive Heart Failure? Perspectives in Cardiology 16 (2): 26-38.

Gwadry-Sridhar, F.H., S. Lawrence, G.E. Marchiori, L. Stitt, and J.M.O. Arnold. 1999. Medication concordance in patients hospitalized with HF: Utilization of community pharmacy records. Canadian Journal of Cardiology 15 (Suppl D): 162-163D.

Moe, G.N., J.L. Rouleau, L. Charbonneau, G. Proulx, and J.M.O. Arnold. 2000. Neurohormonal activation in severe heart failure Relations to patient mortality and the effect of treatment with flosequinan. American Heart Journal 139 (4): 957-959.

Parker, A.B., E.R. Azevedo, M.G. Bair, S.J. Smith, J.M.O. Arnold, D.P. Humen, G.W. Moe, J.O. Parker, and R.W. Butt. 1999. ARCTIC: Assessment of Hemodynamic Response Patients with Congestive Heart Failure to Telmisarton: A Multicentre Dose-ranging Study in Canada. American Heart Journal 135 (5 pt 1): 843-848.

Pitt, B., F. Zannad, W.J. Remme, R. Cody, A. Castaigne, A. Perez, J. Palensky, J. Wittes, and J.M.O. Arnold. 1999. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. New England Journal of Medicine 10 (341): 709-717.

Tsuyuki, R.T., S. Yusuf, T.J. Montague, K.K. Teo, J.M.O. Arnold, R.F. Davies, M.G. Bourassa, A. Horney, and W.O. Williford. 1999. Effects of digoxin on worsening of symptoms of congestive heart failure in the Digitalis Investigation Group (DIG) trial. Circulation 100 (Suppl I): I-537.

BARR, R.M.

BLAKE, P.G.

Blake, P.G. 2000. Adequacy of peritoneal dialysis. Therapy in Nephrology and Hypertension: A Companion to Brenner and Rector's The Kidney. H.R. Brady, and C.S. Wilcox. Philadelphia: WB Saunders. 589-597.

Blake, P.G. 2000. Comparative survival in hemodialysis and peritoneal dialysis. Nephrolgia XX (Suppl 3): 12-15.

Blake, P.G. 2000. Creatinine is the best molecule to target adequacy of peritoneal dialysis. Peritoneal Dialysis International 20 (Suppl 2): S65-S69.

Blake, P.G. 1999. Factors affecting international utilization of peritoneal dialysis: Implications for increasing utilization in the United States. Seminars in Dialysis 12: 365-369.

Blake, P.G. 2000. Peritoneal Dialysis Registry Data. Textbook of Peritoneal Dialysis. R. Gokal, R. Khanna, R. Krediet, and K. Nolph. Dordrecht, The Netherlands: Kluwer Academic Publishers. 785-799.

Blake, P.G. 2000. The relationship between peritoneal clearance and patient outcome in peritoneal dialysis patients. Advances in Peritoneal Dialysis 16: 143-147.

Blake, P.G. 2000. Strategies to achieve peritoneal dialysis adequacy targes. Peritoneal Dialysis Today 6 (1): 16.

Blake, P.G., J.M. Bargman, J. Bick, P. Carier, M.K. Dasgupta, A. Fine, S.D. Savoie, E. Spanner, and P.A. Taylor. 1999. Chapter 5: Guidelines for adequacy and nutrition in peritoneal dialysis. Journal of American Society of Nephrology 10: S311-S321.

Blake, P.G., S.M. Korbet, R. Blake, J.M. Bargman, J.M. Burkart, B.G. Delano, M.K. Dasgupta, A. Fine, F. Finkelstein, F.X. McCusker, S.D. McMurray, P.M. Zabetakis, S.W. Zimmerman, and P. Hiedenheim. 2000. A multicenter study of noncompliance with continuous ambulatory peritoneal dialysis exchanges in US and Canadian patients. American Journal of Kidney Diseases 35: 506-514.

Blake, P.G., W. Van Biesen, N.H. Lameire, and R. Maiorca. 2000. Outcomes and intermodality transfers in patients on renal replacement therapy in Canada and Europe. Complications of Dialysis. N. Lamiere, and R.L. Mehta. New York: Marcel Dekker. 791-810.

Vonesh, E.F., K.O. Story, W.T. O'Neill, P.G. Blake, and The PD Adequest International Study Group. (2000). A multinational clinical validation study of PD Adequest 20. Peritoneal Dialysis International 19: 556-571.

BORRIE, M.J.

Borrie, M.J., S. Lytwynec, N. Griffiths, Z. Knezic, and M. Gagnon. 1999. Outcomes of a New Community-Nurse Continence Service. Annals of the Royal College of Physicians and Surgeons of Canada 32 (6): 346-351.

Misiaszek, B., M.J. Borrie, C.D. Brymer, R.G. Crilly, L. Viana, and Z. Austin. 1999. Canadian University Faculties of Pharmacy Curriculum Survey of Undergraduate Geriatric Content. Clinical and Investigative Medicine 22 (Suppl 4): 155.

Wells, J., M.J. Borrie, R.G. Crilly, C.D. Brymer, and J.S. Hurwitz. 1999. A novel Clinical Pharmacy Experience for third year Medical students. Canadian Journal of Clinical Pharmacology 6 (4).

BOUGHNER, D.R.

Barnett, H.J.M., and D.R. Boughner. 1999. Mitral valve prolapse and stroke in young adults. Journal Watch Neurology 1 (8): 58.

Carew, E.O., I. Vesely, E.A. Talman, and D.R. Boughner. 1999. Quasi-linear viscoelastic theory applied to internal shearing of heart valve tissue. Journal Biomechanical Engineering 4: 386-392.

De Groot, C., M. Drangova, A. Fenster, S. Zhu, P.W. Pflugfelder, and D.R. Boughner. 2000. Evaluation of 3-D Colour Doppler Ultrasound for the Measurement of Proximal Isovelocity Surface Area. Ultrasound in Medicine and Biology 26 (6): 989-999.

Gordon, M., A. Hui, W.K. Wan, and D.R. Boughner. 1999. A new flexible material for mechanical valve prostheses. Canadian Journal of Cardiology 158 (D): 158.

Nadkarni, S.K., D.R. Boughner, M. Drangova, and A. Fenster . 2000. Estimation and theoretical prediction of accuracy and variability in the measurement of left ventricular volume and mass using 3D echocardiography. SPIE: Ultrasonic Imaging and Signal Processing 3982: 47-55.

Nadkarni, S.K., D.R. Boughner, M. Drangova, and A. Fenster . 2000. Three-dimensional echocardiography: assessment of inter-and intra-operator variability and accuracy in the measurement of left ventricular cavity volumes and myocardial masses. Physics in Medicine Biology 45: 1255-1273.

Quinn, R.R., P.W. Pflugfelder, W.J. Kostuk, and D.R. Boughner. 2000. Intracoronary ultrasound imaging: methods and clinical applications. The Canadian Journal of Cardiology 16: 911-917.

Weind, K.L., C.G. Ellis, and D.R. Boughner. 2000. The aortic valve blood supply. Journal Heart Valve Disease 9: 1-8.

BRYMER, C.D.

Man-Son-Hing, M., F. Molnar, P. St. John, C.D. Brymer, and K. Rockwood. 2000. Increasing Physicians' Response Rates to Mailed Surveys: Effect of Investigator's Name Recognition. Annals of the Royal College of Physicians and Surgeons of Canada 33 (1): 7-9.

Misiaszek, B.C., S.S. Gill, C.D. Brymer, R.G. Crilly, P. Stolee, and l. Viana. 1999. Factors contributing to inappropriate prescribing in a canadian long term care setting. Clinical and Investigative Medicine 22 (Suppl 4): 144.

Naugler, C.T., C.D. Brymer, P. Stolee, and Z.A. Arcese. 2000. Development and validation of an Improving Prescribing in the Elderly Tool. Canadian Journal of Clinical Pharmacology 7 (2): 103-107.

Wells, J., M.J. Borrie, R.G. Crilly, C.D. Brymer, and J.S. Hurwitz. 1999. A novel Clinical Pharmacy Experience for third year Medical students. Canadian Journal of Clinical Pharmacology 6 (4).

CHIN-YEE, I.H.

Eichelbronner, O., A. Sielenkamper, G. Cepinskas, W.J. Sibbald, and I.H. Chin-Yee. 2000. Endotoxin promotes adhesion of human erythrocytes to human vascular endothelial cells under conditions of flow. Critical Care Medicine 28 (June): 1865-1870.

Hebert, P.C., I.H. Chin-Yee, M. Blajchman, S. Szick, J.F. Baron, and J.L. Carson. 2000. Should Old Red Cells Be Transfused in Critically Ill Patients. Yearbook of Critical Care and Emergency Medicine. J.L. Vincent. Springer, Heidelberg. 494-506.

Rock, G., I.H. Chin Yee, G. Cantin, A. Giulivi, S. Gluck, A. Keating, M. Keeney, J. Klassen, R. Sutherland, and The Canadian Bone Marrow Transplant Group. 2000. Quality Assurance of Progenitor Cell Content of Apheresis Products: A Comparison of Clonogenic Assays and CD34+ Enumeration. Transfusion Medicine 10 (1): 67-75.

Sielenkamper, A.W., O. Eichelbronner, C.M. Martin, S.W. Madorin, I.H. Chin-Yee, and W.J. Sibbald. 2000. Diaspirin cross-linked hemoglobin improves mucosal perfusion in the ileum of septic rats. Critical Care Medicine 28 (3): 782-787.

Sutherland, D.R., M. Keeney, A. Pecora, and I.H. Chin-Yee. 2000. The ISHAGE Guidelines for CD34+cell determination: Applications in autologous and allogeneic blood and marrow transplantation (Chapter 27). Hematopoietic Stem Cell Therapy. E. Ball, J. Lister, and P. Law. London, England: Harcourt Inc. Churchill Livingstone. 298-311.

CHOW, L.H.

Li, J., X. Han, J. Jiang, R. Zhong, J.G. Pickering, G.M. Williams, and L.H. Chow. 1999. Origin of the intimal smooth muscle cells in sex-mismatched mouse aortic allografts. Circulation 100 (18): I-707.

Li, S., Y. Jiao, L.H. Chow, S. Sims, and J.G. Pickering. 1999. Evidence from cell cloning that distinct smooth muscle cell lineages exist in the normal human internal thoracic artery. Circulation 100 (18): I-209.

Li, S., S. Sims, Y. Jiao, L.H. Chow, and J.G. Pickering. 1999. Evidence from a novel human cell clone that adult vascular smooth muscle cells can convert reversibly between noncontractile and contractile phenotypes. Circulation Research 85: 338-348.

Pickering, J.G., L.H. Chow, S. Li, K.A. Rogers, E. Rocnik, R. Zhong, and B.M.C. Chan. 1999. a5ß1 integrin expression and luminal edge fibronectin matrix assembly by smooth muscle cells following arterial injury. American Journal of Pathology 156: 453-465.

Rocnik, E., L.H. Chow, and J.G. Pickering. 2000. Heat shock protein 47 is expressed in fibrous regions of human atheroma and is regulated by growth factors and oxidized low-density lipoprotein. Circulation 101: 1229-1233.

Wang, H., M.E. DeVries, S. Deng, M.H. Khandaker, J.G. Pickering, L.H. Chow, B. Garcia, D.J. Kelvin, and R. Zhong. 2000. The axis of interleukin 12 and gamma interferon regulates acute vascular xenogeneic rejection. Nature (Medicine) 6: 549-555.

CLARK, W.F.

Clark, W.F. 2000. What's new in lupus nephritis? Canadian Journal of Continued Medical Education 12: 195-203.

Clark, W.F., D.N. Churchill, L. Forwell, G. MacDonald, and S. Foster. 2000. To pay or not to pay? A decision and cost-utility analysis from the state perspective of ACE-inhibitor therapy for diabetic nephropathy. Canadian Medical Association Journal 162: 195-198.

Clark, W.F., G.A. Rock, N. Buskard, K.H. Shumak, P. LeBlond, D. Anderson, and D.M. Sutton. 1999. Therapeutic plasma exchange: an update from the Canadian Apheresis Group. Annals of Internal Medicine 131: 453-462.

CRILLY, R.G.

Crilly, R.G., D. Harris, P. Stollee, and F.K. Ellett. 1999. A framework for development of geriatric services in rural areas. Gerontology and Geriatrics Education 20 (1).

Crilly, R.G., and M. Kloseck. 1999. Satisfaction with Community Health Support Services Among the Elderly. Clinical Investigative Medicine 22 (Suppl 4): 154.

Harris, D., R.G. Crilly, P. Stollee, and F.K. Ellett. 1999. Improving a system of care for the elderly in rural areas. Gastroenterology 39 (3): 362-367.

McKercher, H.G., and R.G. Crilly. 2000. Continuing education in geriatrics: the needs of physicians in northeastern Ontario. Mature Medicine 3 (2): 64-68, 72.

Wells, J., M.J. Borrie, R.G. Crilly, C.D. Brymer, and J.S. Hurwitz. 1999. A novel Clinical Pharmacy Experience for third year Medical students. Canadian Journal of Clinical Pharmacology 6 (4).

CRUICKSHANK, M.

Kovacs, M.J., M. Keeney, K. MacKinnon, L. Wong, M. Cruickshank, E. Boyle, and P. Ainsworth. 1999. Assessment of Activated Protein C Resistance and Factor V Leiden in Patients with Thrombosis and Cancer. Laboratory Hematology 5 (October): 70-73.

Savage, K.J., P.S. Wells, V. Schulz, D. Goudie, B. Morrow, M. Cruickshank, and M.J. Kovacs. 1999. Outpatient Use Of Low Molecular Weight Heparin (Dalteparin) For The Treatment Of Deep Vein Thrombosis Of The Upper Extremity. Thrombosis and Haemostasis 82 (Sept): 1008-1010.

DANTER, W.R.

Danter, W.R., D.B. Gregson, K.A. Ferguson, M.R. Danter, and J. Bend. 2000. A Hybrid Classification Tree and Artificial Neural Network Model for Predicting the In Vitro Response of the Human Immunodeficiency Virus (HIV1) to Anti-Viral Drug Therapy. Artificial Neural Networks in Medicine and Biology, Proceedings of the ANNIMAB-1 Conference. Goteborg, Sweden: 13 May 2000-16 May 2000. H. Malmgren, M. Borga, and L. Niklasson. Perspectives in Neural Computing. London, UK: Springer-Verlag. 235-240.

Kirby, S.D., W.R. Danter, C.F.P. George, T. Frankovic, R.R.F. Ruby, and K.A. Ferguson. 1999. Neural network prediction of obstructive sleep apnea from clinical criteria. Chest 116 (2): 409-415.

EDMONDS, M.W.

Edmonds, M.W., S. Kennedy, B. Schultz, H. Lutfiyya, S. Osborn, M. Bauer, M. Glenn, J.L. Mahon, and G. Doig. 1999. Using the Internet to Monitor Patients with Gestational Diabetes Mellitus. Canadian Journal of Diabetes Care 23: 88.

Feldman, G.L., M.W. Edmonds, P.J. Ainsworth, I. Schuffenecker, G.M. Lenoir, A.W. Saxe, G.B. Talpos, J. Roberson, N. Petrucelli, and C. Jackson. 2000. Variable expressivity of familial medullary thyroid carcinoma (FMTC) due to a RET V804M (GTG ATG) mutation. Surgery 128: 93-98.

Harris, S., S. Tokmakejian, M.W. Edmonds, S. Webster-Bogaert, J.L. Mahon, S. Porter, and T. McDonald. 2000. Validation of the Bayer DCA2000TM as a Point-of-Care Measure of Glycosylated Haemoglobin. Diabetes 49: A110.

FEAGAN, B.G.

Feagan, B.G. 2000. Economic Considerations in IBD Treatment: Mentoring in IBD. Inflammatory Bowel Disease.

Feagan, B.G. 1999. Economic Issues in Crohn's Disease: Assessing the Effects of New Treatments on Health-Related Quality of Life. Alimentary Therapeutics and Pharmacology (Suppl 4): 29-37.

Feagan, B.G. 2000. Historical Perspective on the Role of Azathioprine and 6-MP in the Treatment of Crohn's Disease. Imuran Monograph. The Spellman Group Inc.

Feagan, B.G., M. Bala, M. Vreeland, and L. Larson. 2000. Annual Cost of Care for Crohn's Disease: A Payer's Perspective. American Journal of Gastroenterology 95 (8): 1955-1960.

Feagan, B.G., R.N. Fedorak, E.J. Irvine, G. Wild, L. Sutherland, A.H. Steinhart, G.R. Greenberg, J. Koval, C.J. Wong, M.B. Hopkins, S.B. Hanauer, J.W.D. McDonald, and The North American Crohn's Study Group Investigators. 2000. A Comparison of Methotrexate with Placebo for the Maintenance of Remission in Crohn's Disease. New England Journal of Medicine 342 (22): 1627-1632.

Feagan, B.G., T. Marrie, C. Lau, S. Wheeler, C. Wong, and M. Vandervoort. 2000. The Treatment and Outcomes of Community Acquired Pneumonia at Canadian Hospitals. Canadian Medical Association Journal 162 (10): 1415-1420.

Feagan, B.G., and J. Wong. 1999. Crohn's Disease: Clinical Course, Current Treatment, and Pharmacoeconomics. Remicade Monograph. Schering-Plough Research Paper.

Hanauer, S., B.G. Feagan, and K. Seymour. 1999. Innovations in the Management of Inflammatory Bowel Diseases. Inflammatory Bowel Diseases. S. Hanauer, B.G. Feagan, K. Seymour, D.H. Present, D.B. Sachar, W. Sandborn, S. Targan, W. Tremaine, H. Winter, and D. Wolf. New York: Churchill Livingstone. 1-8.

Marrie, T., C. Lau, S. Wheeler, C. Wong, M. Vandervoort, and B.G. Feagan. 2000. A Controlled Trial of a Critical Pathway for the Treatment of Community Acquired Pneumonia. Journal of the American Medical Association 283 (6): 749-755.

McDonald, J.W.D., A. Burroughs, and B.G. Feagan. 1999. Evidence-Based Gastroenterology and Hepatology. London: British Medical Journal Books. xv, 557 pp.

McDonald, J.W.D., B.G. Feagan, and A. Burroughs. 1999. Introduction to Evidence-Based Gastroenterology and Hepatology. Evidence-Based Gastroenterology and Hepatology. J.W.D. McDonald, A. Burroughs, and B.G. Feagan. London: BMJ Books. 1-15.

Muirhead, N., B.G. Feagan, J.L. Mahon, R.Z. Lewanczuk, N.W. Roger, F. Botteri, P. Oddou-Stock, E. Pecher, and R. Cheung. 1999. The Effects of Valsartan and Captopril on Reducing Microalbuminuria in Patients with Type 2 Diabetes. Current Therapeutic Research Clinical and Experimental 60 (12): 650-660.

Muirhead, N., B.G. Feagan, J.L. Mahon, R. Lewanczuk, W. Rodger, F. Botteri, P. Oddou-Stock, E. Pecher, and R. Cheung. 1999. Valsartan shows Comparable Reduction in Microalbuminuria as Captopril in Patients with Type 2 Diabetes Mellitus. Current Therapeutic Research 60 (12): 650-660.

Palmer, C.S., C. Zhan, A. Elixhauser, M. Halpern, L. Rance, B.G. Feagan, and T. Marrie. 2000. An Economic Evaluation for a Community Acquired Pneumonia Intervention Trial Assessing Levofloxacin Clinical Therapeutics. Clinical Therapeutics 22 (2): 250-264.

Silverstein, M., E.V. Loftus, W.J. Sandborn, W.J. Tremaine, and B.G. Feagan. 1999. Clinical Course and Costs of Care for Crohn's Disease: Markov Model Analysis of a Poplulation-Based Cohort. Gastroenterology 117 (1): 49-57.

Zarnke, K.B., R.D. Feldman, J.L. Mahon, B.G. Feagan, N. Feagan, and N. Schmidt. 1999. Patient-directed blood pressure management using home blood pressure monitors and drug dosage adjustment algorithms: A randomized controlled trial. Circulation 100 (18): I-34.

FELDMAN, R.D.

Barlic, J., J.D. Andrews, A.A. Kelvin, S.E. Bosinger, M.E. DeVries, L. Xu, T. Dobransky, R.D. Feldman, S.S.G. Ferguson, and D.J. Kelvin. 2000. Regulation of tryosine kinase activation and granule release through -arrestin by CXCR1. Nature Immunology 3: 227-233.

Feldman, R.D. 2000. ACE inhibitors versus AT1 blockers in the treatment of hypertension and syndrome X. Canadian Journal of Cardiology 16: 41E-44E.

Feldman, R.D., N.R.C. Campbell, and P. Larochelle. 1999. Clinical problem-solving based on the 1999 Canadian recommendations for the management of hypertension. Canadian Medical Association Journal 161: S18-S22.

Feldman, R.D., N.R.C. Campbell, P. Larochelle, P. Bolli, E.D. Burgess, S.G. Carruthers, J.S. Floras, R.B. Haynes, G.N. Honos, F.H.H. Leenen, L.A. Leiter, A.G. Logan, M.G. Myers, J.D. Spence, and K.B. Zarnke. 1999. The 1999 Canadian recommendations for the management of hypertension. Canadian Medical Association Journal 161 (Suppl 12): S1-S17.

Feldman, R.D., and R.A. Hegele. 2000. G-protein polymorphisms and maternal/neonatal metabolism: still a weight for the answer. The Lancet 355: 1201-1202.

Gros, R., J. Chorazyczewski, M. Meek, J.L. Benovic, S.S.G. Ferguson, and R.D. Feldman. 2000. G-Protein-Coupled Receptor Kinase Activity in Hypertension: Increased Vascular and Lymphocyte GRK2 Protein Expression. Hypertension 35: 38-42.

Xu, L., M.H. Khandaker, R. Rahimpour, C. Kong, L. Ran, G. Mitchell, C.M. Tan, B.M. Gill, M. DeVries, R.D. Feldman, and D.J. Kelvin. 2000. Identification of a novel mechanism for endotoxin-mediated downmodulation of CC chemokine receptor expression. European Journal of Immunology 30: 227-235.

Zarnke, K.B., N. Schmidt, and R.D. Feldman. 2000. How stable are white-coat hyper- and normo-tensive effects over time? American Journal of Hypertension 13 (4): 219A-220A.

FERGUSON, K.A.

Burns, K.E.A., E. Piliotis, B.M. Garcia, and K.A. Ferguson . 2000. A case report of amiodarone pulmonary, neuromuscular, and ophthalmologic toxicity and review of the literature. Canadian Respiratory Journal 7 (2): 193-197.

Kirby, S.D., W.R. Danter, C.F.P. George, T. Frankovic, R.R.F. Ruby, and K.A. Ferguson. 1999. Neural network prediction of obstructive sleep apnea from clinical criteria. Chest 116 (2): 409-415.

Lowe, A.A., T.T. Sjoholm, C.F. Ryan, J.A. Fleetham, K.A. Ferguson, and J.E. Remmers. 2000. Treatment, airway and compliance effects of a titratable oral appliance. Sleep 23 (Suppl 4): S172-S178. Conference Proceedings.

FRAHER, L.J.

Fraher, L.J., and P.H. Watson. 2000. Local Regulators of Bone Turnover. The Osteoporosis Primer. J.E. Henderson, and D. Goltzman. Cambridge: Cambridge University Press. 64-72.

Hodsman, A.B., L.J. Fraher, and P.H. Watson. 1999. Therapeutics: Parathyroid Hormone. The Aging Skeleton. C.J. Rosen, J. Glowacki, and J.P. Bilezikian. San Diego: Academic Press. 563-578.

Hodsman, A.B., M. Kisiel, J.D. Adachi, L.J. Fraher, and P.H. Watson. 2000. Histomorphometric evidence for increased bone turnover without chancge in cortical thickness or porosity after 2 years of cyclical hPTH (1-34) therapy in women with severe osteoporosis. Bone 27 (2): 311-318.

Toogood, J.H., A.B. Hodsman, L.J. Fraher, A.E. Markov, and Baskerville. 2000. Serum osteocalcin and procollagen as markers for the risk of osteoporotic fracture in corticosteroid-treated asthmatic adults. Journal of Allergy and Clinical Immunology 104 (4): 769-774.

Watson, C.S., S.E. White, J.H. Homan, L.J. Fraher, J.F. Brien, and A.D. Bocking. 2000. The adenosine A(1)-receptor antagonist *-CPT reverses ethanol-induced inhibition of fetal breathing movements. Journal of Applied Physiology 87 (4): 1333-1338.

Watson, P.H., L.J. Fraher, G.N. Hendy, U.I. Chung, M. Kisiel, B.V. Natale, and A.B. Hodsman. 2000. Nuclear localization of the type 1 PTH/PTHrP receptor in rat tissues. Journal of Bone and Mineral Research 15 (6): 1033-1044.

Watson, P.H., L.J. Fraher, B.V. Natale, M. Kisiel, G.N. Hendy, and A.B. Hodsman. 2000. Nuclear localization of the type I parathyroid hormone/parathyroid hormone-related peptide receptor in MC3T3-E1 cells:association with serum induced cell proliferation. Bone 26 (3): 221-225.

Whitfield, J.F., P. Moreley, L.J. Fraher, A.B. Hodsman, D.W. Holdsworth, P.H. Watson, G.E. Willick, J.R. Barbier, M. Gulam, R.J. Issacs, S. MacLean, and V. Ross. 2000. The stimulation of vertebral and tibial bone growth by the parathyroid hormone fragments, hPTH-(1-31)NH2, [Leu27]cyclo(Glu22-Lys26)hPTH-(1-31)NH2, and hPTH-(1-30)NH2. Calcified Tissues International 66 (4): 307-312.

FREEMAN, D.J.

Parnes, L.S., A.H. Sun, and D.J. Freeman. 1999. Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope 109 (7 pt 2): 1-17.

GEORGE, C.F.P.

George, C.F.P. 1999. To sleep, perchance to dream to snore to feel refreshed. Ontario Thoracic Reviews 11 (3): 3.

George, C.F.P. 2000. Vigilance Impairment: Assessment by Driving Simulators. Sleep 23 (Suppl 4): S115-118.

George, C.F.P., and S.M. Singh. 2000. Hypocretin (Orexin) pathway to sleep. The Lancet 355: 6.

Juniper, M., M.A. Hack, C.F.P. George, R.J.O. Davies, and J.R. Stradling. 2000. Steering simulation performance in patients with obstructive sleep apnea and matched control subjects. European Respiratory Journal 15: 590-595.

Kirby, S.D., W.R. Danter, C.F.P. George, T. Frankovic, R.R.F. Ruby, and K.A. Ferguson. 1999. Neural network prediction of obstructive sleep apnea from clinical criteria. Chest 116 (2): 409-415.

GILKINSON, T.

Price, L., and T. Gilkinson. 1999. Malignant Superior Vena Cava Syndrome Presenting after Trauma. Canadian Journal of Emergency Medicine 1 (July): 2.

GREGOR, J.C.

Gregor, J.C. 1999. Celiac Disease: Diagnosis, Treatment and Prognosis (Chapter 7). Evidence Based Gastroenterology and Hepatology. J. McDonald, A. Burroughs, and B. Feagan. London, England: BMJ Books. 151-161.

Keenan, S.P., J.C. Gregor, W.J. Sibbald, D. Cook, and A. Gafni. 2000. Noninvasive positive pressure ventiliation in the setting of severe, acute exacerbations of chronic obstructive pulmonary disease: More effective and less expensive. Critical Care Medicine 28 (6): 2094-2102.

Myers, R.P., J.C. Gregor, and P.J. Marotta. 2000. The Cost-Effectiveness of Hepatitis A Vaccination in Patients with Chronic Hepatitis C. Hepatology 31 (4): 824-829.

Myers, R.P., J.C. Gregor, and P.J. Marotta. 2000. The cost-effectivenss of hepatitis A vaccination in patients with chronic hepatitis C. Hepatology 31: 834-839.

Panaccione, R., J.C. Gregor, R.P.E. Reynolds, and H.G. Preiksaitis. 1999. Intrasphincteric botulinum toxin versus pneumatic dilatation for achalasia: a cost minimization analysis. Gastrointestinal Endoscopy 50: 492-498.

HODSMAN, A.B.

Gulam, M., M.M. Thornton, A.B. Hodsman, and D.W. Holdsworth. 2000. Bone mineral measurement of the phalanges: comparison of radiographic absorptiometry and area dual energy x-ray absorptiometry. Radiology 216: 586-591.

Hodsman, A.B. 2000. PTH Peptides as Anabolic Agents in Bone. The Osteoporosis Primer. J.E. Henderson, and D. Goltzman. Cambrige, UK: Cambridge University Press. 331-346.

Hodsman, A.B., and The Canadian Bone Metabolism Board. 1999. Management of corticosteroid-induced osteoporosis. Seminars in Arthritis and Rheumatism 29: 228-251.

Hodsman, A.B., L.J. Fraher, and P.H. Watson. 1999. Therapeutics: Parathyroid Hormone. The Aging Skeleton. C.J. Rosen, J. Glowacki, and J.P. Bilezikian. San Diego: Academic Press. 563-578.

Hodsman, A.B., and The Scientific Advisory Board of the Osteoporosis Society of Canada. 1999. Diagnostic Technologies: Position statement of the Osteoporosis Society of Canada. Osteoporosis Update, 3. Osteoporosis Society of Canada.

Rittmaster, R.S., M. Bolognese, M.P. Ettinger, D.A. Hanley, A.B. Hodsman, D.L. Kendler, and C.J. Rose. 2000. Enhancement of bone mass in osteoporotic women with parathyroid hormone followed by alendronate. Journal of Clinical Endocrinology and Metabolism 85: 2122-2134.

HOUSE, A.A.

Cil, T., I.S. Tummon, A.A. House, B. Taylor, G. Hooker, J. Franklin, R. Rankin, and M. Carey. 2000. A tale of two syndromes: Ovarian hyperstimulation and abdominal compartment. Human Reproduction 15 (5): 1058-1060.

House, A.A., G.A. Wells, J.G. Donnelly, S.P. Nadler, and P.C. Hebert. 2000. Randomized trial of high-flux vs low-flux haemodialysis: Effects on homocysteine and lipids. Nephrology Dialysis Transplantation 15 (7): 1029-1034.

Ooi, D.S., J.P. Veinot, G.A. Wells, and A.A. House. 1999. Increased mortality in hemodialyzed patients with elevated serum troponin T: a one year outcome study. Clinical Biochemistry 32 (8): 647-652.

HOWARD, J.

Atkison, P., S. Williams, J. Howard, W. Wall, K. Paradis, E. Seidman, and D. Grant. (1999). Neoral cyclosporine as maintenance immunosuppression in paediatric small bowel transplantation. Transplant Proceedings 30 (5): 1973-1974.

HOWSON-JAN, K.

English, K.E., W.F. Brien, K. Howson-Jan, and M.J. Kovacs. 2000. Acquired Factor VIII Inhibitor in a Patient With Chronic Myelogenous Leukemia Receiving Interferon Therapy. The Annals of Pharmacotherapy 6 (June): 737-739.

English, K.E., W.F. Brien, K. Howson-Jan, and M.J. Kovacs. 2000. Acquired factor VIII inhibitor in a patient with chronic myelogenous leukemia receiving interferon-alfa therapy. Annals of Internal Medicine 34: 737-739.

Khandaker, M.H., S.A. Kadhim, T.E. Ichim, K. Howson-Jan, J. Chin, and S.K. Singhal. 2000. Prevention of bladder tumor formation in mice by a novel bone marrow-derived factor, reptimed. Anticancer Research 20: 183-189.

HRAMIAK, I.M.

Dupre, J., M.T. Behme, I.M. Hramiak, and T.J. McDonald. 1999. Glucagon-Like Peptide 1 Imrpoves Blood Glucose Levels Through a 5-Day Period in Both Type 1 and Type 2 Diabetes. Diabetes Care 23: 105.

Hegele, R.A., H. Cao, C.M. Anderson, and I.M. Hramiak. 2000. Heterogeneity of Nuclear Lamin A Mutations in Dunnigan-Type Familial Partial Lipodystrophy. Journal of Clinical Endocrinology and Metabolism 85: 3431-3435.

Hegele, R., H. Cao, C. Anderson, and I.M. Hramiak. 2000. Familial Partial Lipodystrophy: Autosomal Dominant Insulin Resistance with Hyperlipidemia, Hypertension and Diabetes due to Mutations in Nuclear Lamin A. Journal of Endocrinology and Metabolism 85: 3431.

Hramiak, I.M., and The Diabetes Control and Complications Trial Research Group. 2000. Retinopathy and Nephropathy in Patients with Type 1 Diabetes Four Years After a Trial of Intensive Therapy. New England Journal of Medicine 342: 381-389.

HUMEN, D.P.

Haykowsky, M.J., K.T. Koon, A.H. Quinney, D.P. Humen, and D. Taylor. 2000. Effects of Long Term Resistance Training on Left Ventricular Morphology. Canadian Journal of Cardiology 15 (1): 35-38.

Haykowsky, M., D.P. Humen, K. Teo, A. Quinney, M. Souster, G. Bell, and D. Taylor. 2000. Effects of 16 weeks of Resistance Training on Left Ventricular Morphology and Systolic Function in Health Mean >60 Years of Age. American Journal of Cardiology 85 (April): 1002-1006.

King, K.M., D.P. Humen, and K.K. Teo. 1999. Cardiac rehabilitation: The forgotten intervention. Canadian Journal of Cardiology 15 (9): 979-985.

Manyari, D.E., D.P. Humen, and M. Knudtson. 1999. Nuclear cardiology after angioplasty and stent placement: Beyond sensitivity and specificity. Journal of the American College of Cardiology 34 (4): 42-44.

McAlister, F.A., K.K. Teo, M. Taher, T.J. Montague, D.P. Humen, L. Chung, M. Kiaii, R. Yim, and P.W. Armstrong. 1999. Insights into the contemporary epidemiology and outpatient management of congestive heart failure. American Heart Journal 138 (1): 87-94.

McKelvie, R.S., S. Yusuf, D. Pericak, A. Avezum, R.J. Burns, J. Probstefield, R.D. Tsuyuki, M. White, J. Rouleau, R. Latini, A. Maggioni, J. Young, J. Pogue, D.P. Humen, and The RESOLVD Pilot Study. 1999. Comparison of Candersartan, Enalapril and their combination in Congestive Heart Failure Randomized Evaluation of Strategies for Left Ventricular Dysfuntion (RESOLVD) Pilot Study. Circulation 100 (10): 1056-1064.

HURWITZ, J.S.

Wells, J., M.J. Borrie, R.G. Crilly, C.D. Brymer, and J.S. Hurwitz. 1999. A novel Clinical Pharmacy Experience for third year Medical students. Canadian Journal of Clinical Pharmacology 6 (4).

JABLONSKY, G.

Boyd, W.D., B. Kiaii, R. Rayman, S. Ganapathy, W.B. Dobkowski, G. Jablonsky, R.J. Novick, F.N. McKenzie, and A.H. Menkis. 1999. Improving Outcome In Off-pump/minimal Access Surgery With Robotic Assistance And Video Enhancement. Canadian Journal of Cardiology 15: 201.

Jablonsky, G., and The ASSENT-2 Investigators. 1999. Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction. Lancet 354.

Kiaii, B., W.D. Boyd, R. Rayman, W.B. Dobkowski, S. Ganapathy, G. Jablonsky, and R.J. Novick. 2000. Robot- Assisted Computer Enhanced Closed-Chest Coronary Surgery: Preliminary Experience Using A Harmonic Scalpel and ZEUS. Heart Surgery Forum 3: 194-197.

JEVNIKAR, A.M.

Gao, J.-X., J. Zhang, C. Awaraji, M. Bhatia, A.M. Jevnikar, B. Singh, D. Bell, and T.L. Delovitch. 2000. Preferential proliferation and differentiation of double-positive thymocytes into CD8+ single- positive thymocytes in a novel cell culture medium. Cell Immunology 202 (1): 41-53.

Ma, S., and A.M. Jevnikar. 2000. Production of autoantigens in plants for oral immunotherapy of autoimmune diseases. Developments in Plant Genetics & Breeding 5: 239-248.

KLEIN, G.J.

Barlow, M.A., G.J. Klein, C.S. Simpson, F.D. Murgatroyd, R. Yee, A.D. Krahn, and A.C. Skanes. 2000. Electrogram Characteristics Predictive of Successful Radiofrequency Catheter Ablatin of Accessory Pathways. Journal of Cardiovascular Electrophysiology 2: 146-154.

Barlow, M.A., G.J. Klein, C.S. Simpson, F.D. Murgatroyd, R. Yee, A.D. Krahn, and A.C. Skanes. 2000. Unipolar electrogram characteristics predictive of successful radiofrequency catheter ablation of accessory pathways. Journal of Cardiovascular Electrophysiology 11: 146-154.

Chauhan, V., A.D. Krahn, G.J. Klein, R. Yee, and A.C. Skanes. 2000. Utility of sequential lidocaine and potassium infusion in the diagnosis of long QT syndrome. Pacing and Clinical Electrophysiology 23: 688.

Connolly, S.J., C.R. Kerr, M. Gent, R.S. Roberts, S. Yusuf, A.M. Gillis, M.H. Sami, M. Talajic, A.S.L. Tang, G.J. Klein, C. Lau, D.M. Newman, and The Canadian Trial of Physiologic Pacing Investigators. 2000. Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. New England Journal of Medicine 342: 1385-1391.

Connolly, S.J., A.D. Krahn, and G.J. Klein. 2000. Long Term Management of the Survivor of Ventricular Fibrillation or Sustained Ventricular. Canadian Journal of Cardiology 16 (C): 20C-22C.

Connolly, S., C. Kerr, M. Talajic, G.J. Klein, M. Green, J. Boone, R. Sheldon, P. Dorian, K.H. Humphries, and J. Spinelli. 1999. New onset atrial fibrillation: Anticoagulant use in the Canadian Registry of Atrial Fibrillation (CARAF). Circulation 100: I500.

Cosio, F.G., R.H. Anderson, K.-H. Kuck, A. Becker, M. Borggrefe, R.W.F. Campbell, F. Gaita, G.M. Guiraudon, M. Haissaguerre, J.J. Rufilanchas, G. Thiene, H.J.J. Wellens, J. Langberg, D.G. Benditt, S. Bharati, G.J. Klein, F. Marchlinski, and S. Saksena. 1999. Living anatomy of the atrioventricular junctions: A guide to electrophysiologic mapping. Circulation 100: E31-E37. Circulation Electronic Pages: www.ahajournals.org.

Finan, J., M. Braney, R. Yee, A.D. Krahn, G.J. Klein, and A.C. Skanes. 1999. Symptom profiles in patients with cardiac arrhythmias: Assessment by a new questionnaire. Canadian Journal of Cardiology 15: 188D.

Guiraudon, G.M., G.J. Klein, C.M. Guiraduon, R. Yee, and D. Switzer. 2000. Surgical Treatment of Ventricular Tachycardias. Cardiac Electrophysiology From Cell to Bedside. 3rd ed. D.P. Zipes, and J. Jalife. Philadelphia, PA: WB Saunders Co. 1078-1086.

Gula, L., A.D. Krahn, A.C. Skanes, R. Yee, and G.J. Klein. 2000. Heart rate variability in obstructive sleep apnea: Effect of continuous positive airway pressure. Pacing and Clinical Electrophysiology 23: 733.

Kerr, C.R., M. Talajic, S.J. Connolly, G.J. Klein, M. Green, R. Sheldon, P. Dorian, K.H. Humphries, and J.J. Spinelli. 1999. Recurrence of atrial fibrillation following its initial diagnosis: follow-up of the Canadian Registry of Atrial Fibrillation (CARAF). Circulation 100: 1286.

Klein, G.J., A.D. Krahn, R. Yee, and A.C. Skanes. 2000. The implantable loop recorder: The herald of a new age of implantable monitors. PACE 23 (1).

Krahn, A.D., G.J. Klein, A.P. Fitzpatrick, A. Zaida, K. Seidl, and R. Yee. 1999. Is there a role for empiric pacing in patients withunexplained syncope? Analysis of 206 patients undergoing prolonged monitoring. Circulation 100 (18): 1-20.

Krahn, A.D., G.J. Klein, B. Spindler, R. Yee, and A.C. Skanes. 2000. Randomized assessment of syncope trial: Comparison of the implantable loop recorder with conventional diagnostic testing for unexplained syncope. Pacing and Clinical Electrophysiology 23: 601.

Krahn, A.D., G.J. Klein, R. Yee, and A.C. Skanes. 1999. Channel-specific testing in Long QT Syndrome: Response of the QT interval to a simplified lidocaine and potassium infusion. Circulation 100 (18): 1-80.

Krahn, A.D., G.J. Klein, R. Yee, and A.C. Skanes. 1999. Recording that Elusive Rhythm. Canadian Medical Association Journal 161 (11): 1424-1425.

Krahn, A.D., P. Pflugfelder, A.C. Skanes, R. Yee, G.J. Klein, F. Murgatroyd, and C. Simpson. 1999. QT adaptation to exercise: RT interval hysteresis in cardiac transplant patients compared to long QT syndrome patients and controls. Pacing and Clinical Electrophysiology 22: 752.

Krahn, A.D., S.M. Renner, G.J. Klein, R. Yee, A.C. Skanes, and E.M. Evans. 2000. The Utility of Holter Monitering compared to Loop Recorders in the evaluation of Syncope and Presyncope. Annals of Non-Invasive Electrocardiology 5 (3): 245-250.

Krahn, A.D., J. Wang, B. Spinder, A.C. Skanes, R. Yee, G.J. Klein, and R.A. Hegele. 2000. A Novel Mutation in KVLQT1, L122P, Found in a Family with Autosomal Dominant Long QT Syndrome. American Heart Journal 140 (1): 146-149.

Lee, J.K., G.J. Klein, A.D. Krahn, R. Yee, K.B. Zarnke, C. Simpson, A.C. Skanes, and B. Spindler. 1999. Rate-control versus Conversion Stategy in Post-operative Atrial Fibrillation: A prospective randomized pilot study. Circulation 100 (18): I-502.

Lee, J.K., R. Yee, G.J. Klein, A.D. Krahn, and A.C. Skanes . 2000. Electrophysiology studies in the assessment and management of patients involved in high risk occupations and activities: An update. Cardiac Electrophysiology Review 4: 89-95.

LeLorier, P., A.C. Skanes, A.D. Krahn, R. Yee, and G.J. Klein. 2000. Paradoxical increase in local VA time with loss of ipsilateral bundle branch block during AVRT: Further evidence of oblique pathways. Pacing and Clinical Electrophysiology 23: 647.

Simpson, C.S., M.A. Barlow, A.D. Krahn, G.J. Klein, R. Yee, and A.C. Skanes. 2000. Recurrent Seizure Diagnosed by the Insertable Loop Recorder (ILR). Journal of Int Cardiovascular Electrophysiology 4: 475-479.

Simpson, C.S., A. Shafquat, M.A. Barlow, G.J. Klein, A.D. Krahn, A.C. Skanes, and R. Yee. 2000. Adenosine in sinus rhythm predicts dual pathway physiology and an atrioventricular nodal reentrant mechanism in patients with supraventricular tachycardia. Pacing and Clinical Electrophysiology 23: 556.

Skanes, A.C., M. Dubuc, G.J. Klein, A.D. Krahn, and R. Yee . 2000. Catheter cryomapping and cryoablation of supraventricular tachycardia in man: Preliminary results. Pacing and Clinical Electrophysiology 23: 613.

Skanes, A.C., M. Dubuc, G.J. Klein, A.D. Krahn, and R. Yee . 2000. New markers to guide slow pathway ablation utilizing a novel cryothermal catheter. Pacing and Clinical Electrophysiology 23: 613.

Skanes, A.C., A.D. Krahn, R. Yee, and G.J. Klein. 2000. AV Nodal Modification for Ventricular Rate Control of Atrial Fibrillation. Atrial AV Nodal Electrophysiology: A View for the Millenium. T.N. Mazgalev, and P.J. Tchou. Armonk, NY: Futura Publishing Co. 447-465.

Talajic, M., C.R. Kerr, K.H. Humphries, G.J. Klein, J. Boone, M.S. Green, and J.J. Spinelli. 1999. New onset atrial fibrillation following open heart surgery: Burden of AF following discharge. Circulation 100: 1288.

Yee, R., G.J. Klein, and E. Prystowsky. 2000. The Wolff-Parkinson-White Syndrome and related variants. Cardiac Electrophysiology From Cell to Bedside. 3rd ed. D.P. Zipes, and J. Jalife. Philadelphia, PA: WB Saunders Co. 845-861.

KOSTUK, W.J.

Carrier, M., M. Rivard, W.J. Kostuk, D. Latter, P. Daly, R. Davies, T. Koon, V. Gudas, J. Sullivan, M. White, and The Investigators of the CASCADE Study. 1999. The Canadian study of cardiac transplantation atherosclerosis. The Canadian Journal of Cardiology 15 (12): 1337-1344.

Levine, T.B., P.J.L.M. Bernink, A. Caspi, U. Elkayam, E.M. Geltman, B. Greenberg, W.J. McKenna, J.K. Ghali, T.D. Giles, A. Maromor, L.H. Reisin, S. Ammon, E. Lindberg, W.J. Kostuk, and The Mach-1 Investigators. 2000. Effect of Mibefradil, a T-Type calcium channel blocker on morbidity and mortality in moderate to severe congestive heart failure. Circulation 101: 758-764.

O'Neill, W.W., P. Serruys, M. Knudtson, G.A. van Es, G.C. Timmis, C. van der Zwaan, J. Kleiman, J. Gong, E.B. Roecker, R. Dreiling, J. Alexander, R. Anders, W.J. Kostuk, and The EXCITE Trial Investigators. 2000. Long-term treatment with a platelet glycoprotein-receptor antagonist after percutaneous coronary revascularization. New England Journal of Medicine 342 (18): 1316-1324.

Packer, M., P.A. Poole-Wilson, P.W. Armstrong, J.G.F. Cleland, J.D. Horowitz, B.M. Massie, L. Ryden, K. Thygensen, B.F. Uretsky, W.J. Kostuk, and The ATLAS Study Group. 1999. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril on morbidity and mortality in chronic heart failure. Circulation 100: 2312-2318.

Quinn, R.R., P.W. Pflugfelder, W.J. Kostuk, and D.R. Boughner. 2000. Intracoronary ultrasound imaging: methods and clinical applications. The Canadian Journal of Cardiology 16: 911-917.

Toal, C.B., M. Motro, M.G. Baird, P. Klinke, Sclarowski S., A. Zilberman, A. Marmor, W.J. Kostuk, C. Lotan, A. Weiss, P. Erne, Palant A., D. Stolero, L. Belanger, and A. Turpie. 1999. Effectiveness of nifedipine GITS in combination with atenolol in chronic stable angina. Canadian Journal of Cardiology 15: 1103-1109.

KOVACS, M.J.

Kemp, K.M., P.J. McCusker, and M.J. Kovacs. 2000. Maternal Non-Hodgkin's Lymphoma Exhibiting PostPartum Clinical Transformation. Journal of the Royal College of Physicians and Surgeons of Canada 33 (4): 219-221.

Kovacs, M.J. 2000. Modern Management of Venous Thromboembolism. The Canadian Journal of Continuing Medical Education 12 (4): 101-117.

Kovacs, M.J., D. Anderson, B. Morrow, L. Gray, D. Touchie, and P.S. Wells. 2000. Outpatient Treatment of Pulmonary Embolism with Dalteparin. Thrombosis and Haemostasis 83 (2): 209-211.

Maharaj, S., C.D. Bayliff, and M.J. Kovacs. 1999. Successful Anticoagulation of a Patient with Mechanical Heart Valves using Low Molecular Weight Heparin (Dalteparin). The Annals of Pharmacotherapy 33 (Nov): 1188-1191.

KRAHN, A.D.

Connolly, S.J., A.D. Krahn, and G.J. Klein. 2000. Long Term Management of the Survivor of Ventricular Fibrillation or Sustained Ventricular. Canadian Journal of Cardiology 16 (C): 20C-22C.

Klein, G.J., A.D. Krahn, R. Yee, and A.C. Skanes. 2000. The implantable loop recorder: The herald of a new age of implantable monitors. PACE 23 (1).

Krahn, A.D., G.J. Klein, R. Yee, and A.C. Skanes. 1999. Recording that Elusive Rhythm. Canadian Medical Association Journal 161 (11): 1424-1425.

Nyman, J.A., A.D. Krahn, P.C. Bland, S. Griffiths, and V. Manda. 1999. The Costs of Recurrent Syncope of Unknown Origin in Elderly Patients. Pacing and Clinical Electrophysiology 22 (9): 1386-1394.

Sheldon, R., S. Connolly, A.D. Krahn, R. Roberts, M. Ghent, M. Gardner, and The CIDS Investigators. 2000. Identification of Patients Most Likely to Benefit From ICD Therapy: The Canadian Implantable Defibrillator Study. Circulation 101 (14): 1660-1664.

LAURIER, L.G.

Wade, G.R., L.G. Laurier, H.G. Preiksaitis, and S.M. Sims. 1999. Delayed rectifier and Ca2+-dependent K+ currents in human esophagus: roles in regulating muscle contraction. American Journal of Physiology (Gastrointestinal and Liver Physiology) 277: G885-G895.

Wolfe, B.M., P.H.R. Barrett, L.G. Laurier, and M.W. Huff. 1999. Effects of continuous conjugated estrogen and micronized progesterone therapy upon lipoprotein metabolism in postmenopausal women. Journal of Lipid Research 41: 368-375.

LEASA, D.

Ostermann, M., E. Ralph, M. Sharpe, and D. Leasa. 2000. Multiorgan failure after a sore throat: A case of Lemierre's syndrome. Clinical Intensive Care 11 (2): 107-109.

LEWIS, J.F.

Malloy, J., R. Veldhuizen, and J.F. Lewis. 2000. Effects of ventilation on the surfactant system in sepsis-induced lung injury. Journal of Applied Physiology 88: 401-408.

Mason, R.J., and J.F. Lewis. 2000. Pulmonary Surfactant. Textbook in Respiratory Medicine. 3rd ed. Murray, Nadel, Boushey, and Mason. W.B. Saunders Company. 307-325.

Puligandla, P., T. Gill, L. McCaig, L.-J. Yao, R. Veldhuizen, F. Possmayer, and J.F. Lewis. 2000. The alveolar environment influences the metabolic and biophysical properties of exogenous surfactants. Journal of Applied Physiology 88: 1061-1071.

Spragg, R., R. Smith, K. Harris, and J.F. Lewis. 2000. Effect of recombinant SP-C surfactant in a porcine lavage model of acute lung injury. Journal of Applied Physiology 88: 674-681.

Webert, K.E., J. Vanderzwan, M. Duggan, J.A. Scott, D.G. McCormack, J.F. Lewis, and S. Mehta. 2000. Effects of inhaled nitric oxide in a rat model of pseudomonas aeruginosa pneumonia. Critical Care Medicine 28 (7): 2397-2405.

LINDSAY, R.

Kianfar, C., C. Rothera, and R. Lindsay. 1999. On-line optical sensing of blood volume changes to prevent intradialytic hypovolemia. Canadian Association of Nephrology Nurses and Technician Journal 9 (4): 29-34.

Kianfar, C., L. Werden, C. Rothera, L. Workentin, P. Watson, and R. Lindsay. 1999. CQI: Hemodialysis vascular access flow monitoring. Canadian Association of Nephrology Nurses and Technicians Journal 9 (3): 42-45.

LLOYD, D.

Klinkenberg-Knoll, E.C., F. Nelis, J. Dent, P. Snel, B. Mitchell, P. Pritchard, D. Lloyd, and The Long-Term Study Group. 2000. Long-Term Omeprazole Treatment in Resistant Gastroesophageal Reflux Disease: Efficacy, Safety and Influence on Gastric Mucosa. Gastroenterology 118 (4).

MAHON, J.L.

Dupre, J., and J.L. Mahon. 2000. Diabetes-related autoantibodies and the selection of subjects for trials of therapies to preserve pancreatic-cell function in recent-onset type 1 diabetes (Editorial). Diabetes Care 23: 1057-1058.

Mahon, J.L. 2000. Direct and indirect randomized trials of screening: the A's and D's of evidence-based clinical practice guidelines (unsolicited commentary). Canadian Medical Association Journal 162: 1002-1004.

Mahon, J.L., and J. Dupre. 2000. Early Detection and Prevention of Diabetes. Evidence-Based Diabetes Care. H.C. Gerstein, and R.B. Haynes. Hamilton, ON: B.C. Decker Inc.

Van Walraven, C., J.L. Mahon, A. Laupacis, C. Bohm, and D. Moher. 1999. What is significant: measuring the minimal clinically important difference in advance of calculating a sample size for a clinical trial. Journal of Clinical Epidemiology 52: 717-723.

MAROTTA, P.J.

Graziadei, I.W., R.H. Wiesner, P.J. Marotta, M.K. Porayko, J.E. Hay, M.R. Charlton, J.J. Poterucha, C.B. Rosen, G.J. Gores, N.F. LaRusso, and R.F. Krom. 1999. Long-Term Results of Patients Undergoing Liver Transplantation for Primary Sclerosing Cholangitis. Hepatology 30: 1121-1127.

Marotta, P.J. 1999. Entering a new age of immunosuppression. Focus 20: 4-5.

Myers, R.P., J.C. Gregor, and P.J. Marotta. 2000. The Cost-Effectiveness of Hepatitis A Vaccination in Patients with Chronic Hepatitis C. Hepatology 31 (4): 824-829.

Myers, R.P., J.C. Gregor, and P.J. Marotta. 2000. The cost-effectivenss of hepatitis A vaccination in patients with chronic hepatitis C. Hepatology 31: 834-839.

MASSEL, D.R.

Little, S., and D.R. Massel. 2000. Risks and benefits of adding anti-platelet therapy of warfarin among patients with prosthetic heart valves: a meta-analysis. Journal of the American College of Cardiology 35.

Massel, D.R. 1999. Access to an outpatient cardiology consultation in southwestern Ontario. Canadian Journal of Cardiology 15: 879-883.

Massel, D.R. 1999. Evidence-based medicine and reteplase: Inductive arguments over deductive reasoning. Canadian Journal of Cardiology 15: 999-1005.

Massel, D.R. 2000. n-3 polyunsaturated fatty acids reduced mortality and morbidity after recent acute myocardial. Evidence Based Medicine (BMJ) 5 (1): 13.

MCCORMACK, D.G.

McCormack, D.G., S. Mehta, K. Tyml, R. Potter, and M. Rohan. 2000. Pulmonary microvascular changes during sepsis: Evaluation using intravital videomicroscopy. Microvascular Research 60: 131-140.

Offman, E., F. Varin, T. Nolan, C.D. Bayliff, A.M. Bombasarro, and D.G. McCormack. 2000. Oral absorption of clarithromycin in acute illness and during convalescence in patients with community-acquired pneumonia. Chest 117: 1090-1094.

Yaghi, A., and D.G. McCormack. 1999. Pulmonary artery contractility in pneumonia: Role of cyclooxygenase products and nitric oxide. Journal of Cardiovascular Pharmacology 34 (3): 468-474.

MCMANUS, R.M.

MEHTA, S.

Little, S., J. Johnson, B. Moon, and S. Mehta. 1999. Painless Left Hemorrhagic Pleural Effusion - Unusual Presentation of Dissecting Ascending Aortic Aneurysm. Chest 116: 1478-1480.

Mehta, S. 1999. Recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children. American Journal of Respiratory and Critical Care Medicine 160: 2104-2117. Invited Conference participant, American Thoracic Society Official Statement.

Mehta, S., and J.M. Drazen. 2000. Nitric Oxide in Pulmonary Processes: Role in Physiology and Pathophysiology of Lung Disease (Chapter 7). Bronchodilator Actions of Nitric Oxide and Related Compounds. M.G. Belvisi, and J. Mitchell. Switzerland: Birkhauser Verlag AG, Basel. 127-149.

Werhun, R., and S. Mehta. 2000. Update on Pathogenesis and Therapy of Pulmonary Sarcoidosis. Ontario Thoracic Review 12 (2): 1,4-7.

MELENDEZ, L.J.

Finnie, K.J.C., and L.J. Melendez. 1999. Acute Coronary Syndrome. Canadian Journal of Diagnosis 17 (11): 61-62.

Finnie, K.J.C., and L.J. Melendez. 1999. Now you see it, Now you don't. Canadian Journal of Diagnosis 18 (1): 57-58.

Finnie, K.J.C., and L.J. Melendez. 1999. Right or Left? Canadian Journal of Diagnosis 17 (8): 52-57.

Finnie, K.J.C., and L.J. Melendez. 2000. Sudden severe chest pain. Canadian Journal of Diagnosis 18 (5): 61-62.

Finnie, K.J.C., and L.J. Melendez. 2000. Unusual pacemaker behavior. Canadian Journal of Diagnosis 18 (3): 59-60.

Hurwitz, G., L.J. Melendez, A. Dick, K. Nagi, N. Suskin, P.E. Radau, P.J. Slomka, and McLaughlin. D.S. 2000. Septal hypoperfusion and septal dyskinesis in left bundle branch block (LBB) and its variants on Tc 99m-Sestamibi (MIBI) images: an objective assessment of 3-dimensional stress tomograms, electrocardiograms, and ECG-Gated immediate post-stress image. Quarterly Journal of Nuclear Medicine 44: 127.

Melendez, L.J., and K.J.C. Finnie. 2000. Broad QRS complex tachycardia. Canadian Journal of Diagnosis 18 (6): 56-57.

Melendez, L.J., and K.J.C. Finnie. 1999. A Change in Pace. Canadian Journal of Diagnosis 17 (7): 51-52.

Melendez, L.J., and K.J.C. Finnie. 2000. Do not wait! Escape! Canadian Journal of Diagnosis 18 (4): 63-64.

Melendez, L.J., and K.J.C. Finnie. 1999. Hide and Seek. Canadian Journal of Diagnosis 17 (10): 69-70.

Melendez, L.J., and K.J.C. Finnie. 1999. How Many P waves? Canadian Journal of Diagnosis 17 (12): 47-48.

Melendez, L.J., and K.J.C. Finnie. 2000. Palpitations. Canadian Journal of Diagnosis 18 (2): 69-70.

Melendez L.J., and K.J.C. Finnie. 1999. The Right Considerations. Canadian Journal of Diagnosis 17 (8): 51-52.

MOIST, L.M.

Moist, L.M., F.K. Port, S.M. Orzol, E.W. Young, T. Ostbye, R.A. Wolfe, T. Hulbert-Shearon, C.A. Jones, and W.E. Bloembergen. 2000. Predictors of Loss of Residual Renal Function among New Dialysis Patients. Journal of the American Society of Nephrology 11: 556-564.

MOOTE, D.W.

Keith, P.K., J. Haddon, S. Birch, J.A. Mazza, D.W. Moote, and The Rhinocort Study Group. 2000. A cost-benefit analysis using a willingness-to-pay questionnaire of intranasal budesonide for seasonal allergic rhinitis. Annals of Allergy, Asthma & Immunology 84: 55-62.

Sussman, G.L., J. Mason, D. Compton, J. Stewart, N. Ricard, J.A. Mazza, and D.W. Moote. 1999. The efficacy and safety of fexofenadine HCl and pseudoephedrine, alone and in combination, in seasonal allergic rhinitis. Journal of Allergy and Clinical Immunology 104 (1): 100-106.

MUIRHEAD, N.

Cheung, R., R.Z. Lewanczuk, N.W. Rodger, M.W. Huff, P. Oddou-Stock, F. Botteri, E. Pecher, and N. Muirhead. 1999. The effect of valsartan and captopril on lipid parameters in patients with type II diabetes mellitus and nephropathy. International Journal of Clinical Practice 53 (8): 584-592.

Foley, R.N., P.S. Parfrey, J. Morgan, P.E. Barre, P. Campbell, P. Cartier, C.D. Coyle, A. Fine, P. Handa, I. Kingma, C.Y. Lau, A. Levin, Mendelssohn, N. Muirhead, B. Murphy, R.K. Plant, G. Posen, and G.A. Wells. 2000. Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy. Kidney International 58 (3): 1325-1335.

Murphy, S.W., R.N. Foley, B.J. Barrett, G.M. Kent, J. Morgan, P. Barre, P. Campbell, A. Fine, M.B. Goldstein, S.P. Handa, K.K. Jindal, A. Levin, H. Mandin, N. Muirhead, R.M. Richardson, and P.S. Parfrey. 2000. Comparative hospitalization of hemodialysis and peritoneal dialysis patients in Canada. Kidney Internatonal 57 (6): 2557-2563.

Murphy, S.W., R.N. Foley, B.J. Barrett, G.M. Kent, J. Morgan, P. Barre, P. Campbell, A. Fine, M.B. Goldstein, S.P. Handa, K.K. Jindal, A. Levin, H. Mandin, N. Muirhead, R.M. Richardson, and P.S. Parfrey. 2000. Comparitive mortality of hemodialysis and peritoneal dialysis in Canada. Kidney International 57 (4): 1720-1726.

Tonelli, M., and N. Muirhead. 2000. Access Type as a Predictor of Dialysis Adequacy in Chronic Hemodialysis Patients. ASAIO Journal 46: 279-282.

PAYTON, K.B.

Payton, K.B. (Co-Editor). 2000. Canadian Journal of Allergy and Clinical Immunology. 5 .

PICKERING, J.G.

Ford, C.M., S. Li, and J.G. Pickering. 1999. Angiotensin II stimulates collagen synthesis in human vascular smooth muscle cells: involvement of the AT1 receptor, transforming growth factor B and tyrosine phosphorylation. Arteriosclerosis, Thrombosis, and Vascular Biology 19: 1843-1851.

Karkanis, T., S. Li, J.G. Pickering, and S. Sims. 1999. Identification and characterization of the inwrdly rectifying K+ channel Kir21 in human internal thoracic artery smooth muscle. Circulation 100 (18): I-846.

Li, S., L. Saward, and J.G. Pickering. 1999. Supermigration of vascular smooth muscle cells on polymerized type I collagen via a matrix autodegradation pathway. Circulation 100 (18): I-753.

Pravda, Z., S. Li, N. Rajakumar, W. Ruschlow, J. Verdi, A. Brown, and J.G. Pickering. 1999. EphrinB3 and ephB3 are coordinately upregulated during human smooth muscle cell maturation. Circulation 100 (18): I-689.

POPE, J.E.

Pope, J.E. 2000. Measurement in Scleroderma Clinical Trials (Chapter 16). Cutaneous Biometrics. D.A. Schwindt, H.I. Maibach, and T.L. Diepgen. New York: Plenum Publishing Corporation. 183-203.

Pope, J.E., and The Ontario Musculoskeletal Therapeutics Review Panel. 2000. Medical Treatment Guidelines for the Treatment of Osteoarthritis, Rheumatoid Arthritis, and Acute Musculoskeletal Injury. Ontario Ministry of Health and Long Term Care 2000. Ontario Ministry of Health: 58 pp.

Pope, J.E., and A. Thompson. 1999. Antimitochondrial antibidies and their significance in diffuse and linited scleroderma. Journal of Clinical Rheumatology (JCR) 5 (4): 206-209.

Pope, J.E., and A. Thompson. 2000. The frequency and significance of anticardiolipin antibodies in scleroderma. 27: 1450-1452.

PREIKSAITIS, H.G.

RALPH, E.

Ostermann, M., E. Ralph, M. Sharpe, and D. Leasa. 2000. Multiorgan failure after a sore throat: A case of Lemierre's syndrome. Clinical Intensive Care 11 (2): 107-109.

Ralph, E. 1999. Powassan Encephalitis. Canadian Medical Association Journal 161: 1416-1417.

REYNOLDS, R.P.E.

Reynolds, R.P.E. 1999. Literature Summary. GI Motility Education Centres Newsletter 3 (2).

RUTLEDGE, F.S.

Hart, J., F.S. Rutledge, M. Sharpe, and W.J. Sibbald. 1999. Post-Operative Cardiac Care: Models and Economic Consideration. New Horizons 4 (7): 551-561.

Inman, K.J., K. Dymock, N. Fysh, B. Robbins, F.S. Rutledge, and W.J. Sibbald. 1999. Pressure Ulcer Prevention: A Randomized Controlled Trial of 2 Risk-Directed Strategies for Patient Surface Assignment. Advances in Wound Care 12 (2): 72-79.

SKANES, A.C.

Berenfeld, O., R. Mandapati, S. Dixit, A.C. Skanes, J. Chen, M. Mansour, and J. Jalife. 2000. Spatially distributed dominant excitation frequencies reveal hidden organization in atrial fibrillation in the Langendorff-perfused heart. Journal of Cardiovascular Electrophysiology 11 (8): 869-879.

Chen, J., R. Madapati, O. Berenfeld, A.C. Skanes, and J. Jalife. 2000. High frequency periodic sources underlie ventricular fibrillation in the isolated rabbit heart. Circulation Research 86: 86-93.

Klein, G.J., A.D. Krahn, R. Yee, and A.C. Skanes. 2000. The implantable loop recorder: The herald of a new age of implantable monitors. PACE 23 (1).

Krahn, A.D., G.J. Klein, R. Yee, and A.C. Skanes. 1999. Recording that Elusive Rhythm. Canadian Medical Association Journal 161 (11): 1424-1425.

Madapati, R., A.C. Skanes, J. Chen, O. Berenfeld, and J. Jalife. 2000. Stable mircroreentrant sources as a mechanism of atrial fibrillation in the isolated sheep heart. Circulation 101: 194-199.

SUSKIN, N.

Demers, C., N. Suskin, and R.S. McKelvie. 2000. Cardiovascular Benefits and Precautions of Regular Physical Activity. Decision Making & Outcomes in Sports Rehabilitation. D.A. Kumbhare, and J.V. Basmajian. Philadelphia: Churchill Livingston. 11-23.

Dick, A., and N. Suskin. 1999. Fitness, fatness, and mortality in men. Clinical Journal of Sports Medicine 9: 187.

Ettler, H.C., M.G. Joseph, P.A. Downing, N. Suskin, and V.C. Wright. 1999. Atypical squamous cells of undetermined significance: A cytohistological study in a colposcopy. Diagnostic Cytopathology 21: 211-216.

Suskin, N. 1999. Physical activity was associated with substantially lower risks of coronary events in middle-age and older women. Evidence Based Cardiovascular Medicine 3.

WHITE, K.P.

White, K.P. 1999. Wounded Workers The Politics of Musculoskeletal Injuries. Pain Research and Management 4 (1): 11.

White, K.P., S. Carette, M. Harth, and R. Teasell. 2000. Trauma and Fibromyalgia: Is there an association and what does it mean? Seminars in Arthritis and Rheumatism 29 (4): 200-216.

White, K.P., and M. Harth. 2000. The occurance and impact of generalized pain. Bailliere's Clinical Rheumatology 13 (3): 379-389.

White, K.P., T. Ostbye, M. Harth, W. Nielson, M. Speechley, R. Teasell, and R. Bourne. 2000. Perspectives on Post-traumatic fibromyalgia: A random survey of Canadian general practitioners, orthopaedists, physiatrists and rheumatologists. Journal of Rheumatology 27 (4): 790-796.

White, K.P., M. Speechley, M. Harth, and T. Ostbye. 2000. Co-existence of Chronic Fatigue Syndrome (CFS) with fibromyalgia syndrome (FMS) in the general. Scandinavian Journal of Rheumatology 29 (1): 44-51.

White, K.P., M. Speechley, M. Harth, and T. Ostbye. 1999. The London Fibromyalgia Epidemiology Study: Comparing the demographic and clinical characteristics in 100 random community cases of fibromyalgia syndrome (FMS) versus controls. Journal of Rheumatology 26 (7): 1577-1585.

White, K.P., M. Speechley, M. Harth, and T. Ostbye. 1999. The London Fibromyalgia Epidemiology Study: The prevalence of fibromyalgia syndrome (FMS) in London, Ontario. Journal of Rheumatology 26 (7): 1570-1576.

WISENBERG, G.

Pereira, R.S., F.S. Prato, K.S. Lekx, J. Sykes, and G. Wisenberg. 1999. Contrast-enhanced MRI for the assessment of myocardial viability after permanent coronary artery occlusion. Magnetic Resonance in Medicine 44: 309-316.

YEE, R.

Klein, G.J., A.D. Krahn, R. Yee, and A.C. Skanes. 2000. The implantable loop recorder: The herald of a new age of implantable monitors. PACE 23 (1).

Krahn, A.D., G.J. Klein, R. Yee, and A.C. Skanes. 1999. Recording that Elusive Rhythm. Canadian Medical Association Journal 161 (11): 1424-1425.

O'Brien, B.J., and R. Yee. 2000. Current evidence of the cost effectiveness of the implantable cardioverter defibrillator. Canadian Journal of Cardiology 16: 45C-47C.

ZARNKE, K.B.

Spence, J.D., and K.B. Zarnke. 2000. Stroke and Hypertension (Chapter 28). Hypertension: A Companion to Brenner & Rector's The Kidney. S. Oparil, and M. Weber. Orlando, FL: W.B. Saunders.

Zarnke, K.B. 1999. Self-determination of blood pressure. Hypertension Canada 61 (B): 5-8.

Zarnke, K.B., and The ALLHAT Collaborative Research Group. 2000. Major cardiovascular events in hypertensive patients randomized to doxazosin vs. Journal of the American Medical Association 283 (15): 1967-1975.

Zarnke, K.B., N.R.C. Campbell, F.A. McAlister, M. Levine, and The Canadian Hypertension Recommendations Working Group. 2000. A Novel Process for Updating Recommendations for Managing Hypertension: Rationale and Methods. Canadian Journal of Cardiology 16 (9): 1094-1102.

Zarnke, K.B., N. Schmidt, and R.D. Feldman. 2000. How stable are white-coat hyper- and normo-tensive effects over time? American Journal of Hypertension 13 (4): 219A-220A.